TRPM2 exhibited similar results; higher expression of TRPM2 had been proven in various cancers including breast cancer, prostate cancer, pancreatic cancer, leukemia, and neuroblastoma [44]. Here, TRPM2 is linked to familial pancreatic carcinoma.